ALEC
Biotechnology · Healthcare
Equibles does not estimate personal net worth.
Get an email with a short summary when Alector, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALEC alertsAlector, Inc. reported in an 8-K filed October 21, 2025 that Dr. Sara Kenkare-Mitra resigned as President and Head of Research and Development, effective December 22, 2025. The same filing states: “Dr. Kenkare-Mitra’s resignation is not the result of any disagreement with the Company related to its operations, policies, or practices.” The proxy statement of Alector, Inc. reports total compensation of $1,575,150 for Dr. Sara Kenkare-Mitra in fiscal 2025, including a base salary of $614,301. Disclosed compensation is on record for 5 fiscal years. Dr. Sara Kenkare-Mitra has spoken on 1 earnings call across 1 company, most recently for Alector, Inc. on August 7, 2025. Alector, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alector, Inc. includes Arnon Rosenthal (CEO and Board Member), Marc Grasso (CFO), Marc Grasso, M.D. (CFO) and 7 others.
“On October 20, 2025, Sara Kenkare-Mitra, Ph.D., President and Head of Research and Development of the Company, informed the Company of her resignation from her position effective December 22, 2025, to pursue other professional opportunities.”
“Dr. Kenkare-Mitra’s resignation is not the result of any disagreement with the Company related to its operations, policies, or practices.”
“As you've heard today, we are advancing our late-stage clinical programs, which have a strong scientific rationale, robust trial designs, and meaningful regulatory engagement.”
Proxy statement
Start not stated–present
Last confirmed April 28, 2026
Proxy statement
Start not stated–2025-12-22
ALEC
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alector, Inc. (ALEC) | Former President and Head of Research and Development | $614,301 | $1,575,150 |
| 2024 | Alector, Inc. (ALEC) | President and Head of Research and Development | $624,367 | $2,549,681 |
| 2023 | Alector, Inc. (ALEC) | President and Head of Research and Development | $598,500 | $2,606,214 |
| 2022 | Alector, Inc. (ALEC) | President and Head of Research and Development | $570,000 | $8,870,409 |
| 2021 | Alector, Inc. (ALEC) | President and Head of Research and Development | $25,942 | $526,841 |
“Dr. Kenkare-Mitra’s resignation is not the result of any disagreement with the Company related to its operations, policies, or practices.”
Alector, Inc. (ALEC)